WallStSmart

American Healthcare REIT, Inc. (AHR)vsDiversified Healthcare Trust (DHC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

American Healthcare REIT, Inc. generates 47% more annual revenue ($2.26B vs $1.54B). AHR leads profitability with a 3.1% profit margin vs -18.6%. AHR earns a higher WallStSmart Score of 46/100 (D+).

AHR

Hold

46

out of 100

Grade: D+

Growth: 6.0Profit: 4.5Value: 3.0Quality: 5.0
Piotroski: 5/9Altman Z: 0.62

DHC

Hold

42

out of 100

Grade: D

Growth: 4.0Profit: 2.0Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -0.02
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AHRSignificantly Overvalued (-162.1%)

Margin of Safety

-162.1%

Fair Value

$19.66

Current Price

$47.94

$28.28 premium

UndervaluedFair: $19.66Overvalued

Intrinsic value data unavailable for DHC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHR1 strengths · Avg: 8.0/10
Price/BookValuation
2.7x8/10

Reasonable price relative to book value

DHC1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Areas to Watch

AHR4 concerns · Avg: 3.0/10
EPS GrowthGrowth
3.1%4/10

3.1% earnings growth

Return on EquityProfitability
2.5%3/10

ROE of 2.5% — below average capital efficiency

Profit MarginProfitability
3.1%3/10

3.1% margin — thin

P/E RatioValuation
114.9x2/10

Premium valuation, high expectations priced in

DHC4 concerns · Avg: 3.5/10
PEG RatioValuation
1.894/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$1.66B3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.613/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : AHR

The strongest argument for AHR centers on Price/Book. Revenue growth of 11.9% demonstrates continued momentum.

Bull Case : DHC

The strongest argument for DHC centers on Price/Book.

Bear Case : AHR

The primary concerns for AHR are EPS Growth, Return on Equity, Profit Margin. A P/E of 114.9x leaves little room for execution misses. Thin 3.1% margins leave little buffer for downturns.

Bear Case : DHC

The primary concerns for DHC are PEG Ratio, Revenue Growth, Market Cap. Debt-to-equity of 1.61 is elevated, increasing financial risk.

Key Dynamics to Monitor

AHR profiles as a value stock while DHC is a turnaround play — different risk/reward profiles.

DHC carries more volatility with a beta of 2.39 — expect wider price swings.

AHR is growing revenue faster at 11.9% — sustainability is the question.

DHC generates stronger free cash flow (28M), providing more financial flexibility.

Bottom Line

AHR scores higher overall (46/100 vs 42/100) and 11.9% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

American Healthcare REIT, Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

American Healthcare REIT, Inc. is a prominent real estate investment trust focused on the acquisition and management of a diversified portfolio of high-quality healthcare facilities across the United States. Specializing in senior housing, skilled nursing, and medical office properties, the company collaborates with leading operators to guarantee stable cash flows and sustainable growth. By prioritizing the enhancement of resident and patient quality of life, American Healthcare REIT is strategically positioned to benefit from the expanding healthcare real estate sector, presenting a compelling investment opportunity for institutional investors in an essential services market.

Visit Website →

Diversified Healthcare Trust

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

DHC is a real estate investment trust, or REIT, that owns medical offices and life science properties, senior communities and wellness centers throughout the United States. The company is headquartered in Newton, MA.

Visit Website →

Want to dig deeper into these stocks?